文献速递眼底病与葡萄膜炎

阿柏西普治疗并延长方案下黄斑新生血管的长期形态学变化

LONG-TERM MORPHOLOGIC CHANGES IN MACULAR NEOVASCULARIZATION UNDER AFLIBERCEPT TREATMENT WITH A TREAT-AND-EXTEND REGIMEN.
PubMed 文献 · Retina · 2023-01-01

回顾性分析25例患者26眼治疗初治新生血管性年龄相关性黄斑变性,接受阿柏西普并延长方案治疗2年。黄斑新生血管面积从基线0.65±0.42 mm²显著增至2年0.78±0.45 mm²,2年面积平均变化22%(四分位距4%-60%)。基线黄斑新生血管面积与2年面积变化率负相关(R=-0.68,P<0.001)。

要点

  • 阿柏西普并延长方案治疗2年,黄斑新生血管面积显著扩大并出现血管成熟。
  • 26眼中9眼(34.6%)出现新形成的成熟血管,7眼(26.9%)原有成熟血管明显发展。
  • 基线黄斑新生血管面积越小,2年内扩大程度越大(R=-0.68,P<0.001)。

核心结论

  • 在阿柏西普并延长方案治疗下,黄斑新生血管扩大并显示血管成熟。
  • 基线黄斑新生血管越小,其2年内扩大程度越大。

研究设计与样本

  • 回顾性研究,分析25例患者26眼诊断为治疗初治新生血管性年龄相关性黄斑变性并接受阿柏西普并延长方案治疗2年的病历资料。
  • 采用扫频源光学相干断层扫描血管成像在基线和治疗2年后评估黄斑新生血管及血管结构面积。

主要发现

  • 平均黄斑新生血管面积从基线0.65±0.42 mm²显著增至2年0.78±0.45 mm²。
  • 2年时黄斑新生血管面积较基线平均变化22%(四分位距4%-60%)。
  • 基线黄斑新生血管面积与2年时较基线的面积变化率呈负相关(R=-0.68,P<0.001)。
  • 26眼中9眼(34.6%)出现新形成的成熟血管,7眼(26.9%)显示原有成熟血管明显发展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the morphologic changes in macular neovascularization (MNV) secondary to age-related macular degeneration after 2 years of aflibercept treatment under a treat-and-extend (T&E) regimen. METHODS: This retrospective study analyzed the medical records for 26 eyes of 25 patients diagnosed with treatment-naive neovascular age-related macular degeneration and treated with aflibercept under a treat-and-extend regimen for 2 years. The areas of the MNV and vascular structures were assessed using swept-source optical coherence tomography angiography at baseline and after 2 years of treatment. RESULTS: The mean MNV area increased significantly from 0.65 ± 0.42 mm 2 at baseline to 0.78 ± 0.45 mm 2 at 2 years. At 2 years, the mean change in the MNV area from baseline was 22% (interquartile range: 4%-60%). The baseline MNV area was negatively correlated with the change ratio of the MNV areas at 2 years and baseline ( R = -0.68, P < 0.001). Nine of the 26 eyes (34.6%) showed newly formed mature vessels, and 7 eyes (26.9%) showed prominently developing preexisting mature vessels. CONCLUSION: Macular neovascularization expanded and showed vascular maturation under aflibercept treatment with a treat-and-extend regimen. The smaller the MNV at baseline, the greater is its expansion in 2 years.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Nakano Y, Takeuchi J, Horiguchi E, et al. LONG-TERM MORPHOLOGIC CHANGES IN MACULAR NEOVASCULARIZATION UNDER AFLIBERCEPT TREATMENT WITH A TREAT-AND-EXTEND REGIMEN. Retina. 2023. PMID: 36730570. doi:10.1097/IAE.0000000000003676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。